Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Daniela Rus, the director of MIT’s Computer Science and Artificial Intelligence Lab, is developing robots that take more cues ...

Rocket Pharmaceuticals has shared early data from three patients that tie its gene therapy for an inherited heart disease to ...

This could give enterprises access to a 3D, AI-accelerated future without requiring investment in costly GPU-scale ...

Rowing machines provide one of the most effective low-impact exercise options to build endurance, lose weight or support whatever fitness journey you’re on. To find the best rowing machines on ...

His ousting of Peter Marks—a senior official at the Food and Drug Administration and key proponent of faster drug approvals—sent biotech stocks tumbling last month and stoked concerns that the ...

Nestlé will open a deep tech center in 2026 to expand its capabilities in fields from robots and smart coffee machines to ...

As Pfizer navigates these challenges, it faces rising competition from agile biotech firms wielding AI, gene editing, and mRNA technologies. By 2030, these innovators could surpass Pfizer’s drug ...